Supplemental Table 3. Comparisons of TG, LDL-C, and HDL-C distributions among various studies.
| Principal investigator | Miller et al. #1 | Miida et al. #2 | Present study |
|---|---|---|---|
| [Reference] | [2010, ref.#10; 2011, ref.#11] | [2012, ref.#5; 2014, ref.#6] | |
| Number of samples (postprandial samples, %) | |||
| Non-diseased group | 37 (5, 13.5%) | 49 (15, 30.6%) | 59 (43, 72.9%) |
| Diseased group | 138 (43, 31.2%) | 124 (55, 44.4%) | 109 (43, 39.4%) |
| Total | 175 (48, 27.4%) | 173 (70, 40.5%) | 168 (86, 51.2%) |
| TG (mg/dL) (Non-diseased/diseased) | |||
| ≥ 1,000 | 3 (0/3) | (5, excluded) | (3, excluded) |
| 600 ∼ 999 | 1 (0/1) | 9 (0/9) | 3 (0/3) |
| 400 ∼ 599 | 3 (0/3) | 8 (0/8) | 5 (0/5) |
| 200 ∼ 399 |  |
29 (0/29) | 34 (0/34) |
| < 199 | 127 (49/78) | 126 (59/67) | |
| LDL-Crmp (mg/dL) | |||
| ≥ 300 | 1 (0/1) | 1 (0/1) | 0 (0/0) |
| 200 ∼ 299 | 4 (0/4) | 4 (0/4) | 5 (0/5) |
| 100 ∼ 199 | 155 (36/119) | 119 (37/82) | 116 (43/73) |
| 50 ∼ 99 | 46 (12/34) | 47 (16/31) | |
| 20 ∼ 49 | 12 (1/11) | 3 (0/3) | 0 (0/0) |
| < 20 | 1 (0/1) | − | (1, excluded) |
| LDL-Crmp, not available | 2 (0/2) | − | − |
| HDL-Crmp (mg/dL) | |||
| ≥ 100 | 1 (0/1) | (1/5)#3 | (6, excluded) |
| 80 ∼ 99 | 7 (5/2) | 18 (10/8) | 7 (5/2) |
| 60 ∼ 79 |
 #1
|
41 (22/19) | 52 (27/25) |
| 40 ∼ 59 | 87 (16/71) | 85 (23/62) | |
| 20 ∼ 39 | 21 (0/21) | 24 (4/20) | |
| < 20 | 4 (0/4) | − | (3, excluded) |
| HDL-Crmp, not available | 1 (0/1) | ||
LDL-Crmp, low-density lipoprotein-cholesterol concentration determined by the reference measurement procedure (RMP); HDL-Crmp, high-density lipoprotein-cholesterol concentration determined by the RMP.
#1
The sample numbers given with the ranges of individual lipoproteins were determined using the data of the two publications, including supplemental data.
#2
The sample numbers given with the ranges of individual lipoproteins were counted using original data.
#3
Those with HDL-C > 100mg/dL were included in the study subjects in ref. #5, but excluded in ref. #6.